Today: 24 April 2026
Why B2Gold Stock Price Is Falling Today as Goose Ramp-Up Risks Return
13 March 2026
1 min read

Why B2Gold Stock Price Is Falling Today as Goose Ramp-Up Risks Return

Vancouver, March 13, 2026, 12:13 PDT

B2Gold Corp shares on the NYSE American slipped almost 5% Friday, joining a slump that swept through gold miners as bullion prices softened. A new annual filing also underscored ongoing execution risks tied to the Goose mine project in Nunavut. By midday in Vancouver, the stock was sitting at $4.86.

The timing’s notable. B2Gold stuck with its 2026 production forecast of 820,000 to 970,000 ounces—lower than the 979,604 ounces it logged in 2025. The miner also lifted its all-in sustaining cost outlook to $2,400 to $2,580 an ounce, well above last year’s $1,584.

So, 2026 shapes up as something of a transition year. B2Gold is projecting output at its Goose mine in Canada between 170,000 and 230,000 ounces for this year, though about 65% of that haul won’t show up until the back half, with crushing-circuit upgrades still underway at the site. The plant’s nameplate capacity stands at 4,000 tonnes daily.

The annual report didn’t mince words. B2Gold flagged that Goose can’t hit full speed until it finishes engineering, procurement, and logistics, with those pieces still outstanding. On top of that, the company cautioned that ongoing permit delays at Fekola Regional in Mali throw a wrench into just how much gold-price upside might actually make it onto their books.

Gold slipped again. Spot prices, Reuters said, dropped 0.5% on Friday, marking another losing week for the metal. Independent trader Tai Wong told the outlet bullion was “grinding towards lows” while the dollar kept climbing. Reuters

Selling hit across the sector. Shares of Newmont, Kinross Gold, and Agnico Eagle each dropped roughly 4% to 5% in U.S. trading—not just a B2Gold story, though that name still faces its own execution issues.

Caution on the sell side is still in play. Markets Insider, referencing TipRanks, noted RBC Capital’s Josh Wolfson stuck with his Hold rating and kept the $6.50 price target as of March 12.

B2Gold is pushing its rebound timeline out. The miner now expects 2027 output to return to 2025 levels. January numbers showed all four mines topping internal forecasts, but the same update spelled out that initial upgrades to crushing at Goose won’t happen until the back half of 2026. Hitting the full 4,000 tonnes per day pace is slated for the first half of 2027.

The shares could take a hit if key deadlines get pushed back. Say Goose upgrades stall, or the Fekola Regional permit faces delays—B2Gold then risks sticking near the lower bound of its output forecast, with costs remaining high. That’s straight from the company’s own guidance and risk disclosures.

B2Gold hit a new high for gold revenue in 2025, pulling in $3.06 billion. Net income landed at $427 million. Year-end cash? $380 million. The board signed off on a $0.02 per share dividend for the first quarter, with payment set for March 19.

Stock Market Today

  • Nuvation Bio (NUVB) Share Price Surges Amid Mixed Valuation Signals
    April 23, 2026, 11:58 PM EDT. Nuvation Bio's stock rose 4.8% over the past week and 17.8% over 30 days, despite a 41.3% year-to-date decline. The company's drug development progress has spurred investor interest. A Discounted Cash Flow (DCF) analysis shows the stock could be undervalued by 86.7%, with an intrinsic value of about $38 per share versus the current $5.04 price. However, valuation using the Price-to-Sales (P/S) ratio paints a different picture; Nuvation Bio trades at 27.86x sales, significantly higher than the Pharmaceuticals industry average of 4.88x and peer average of 11.51x. The contrasting signals highlight uncertainty about the stock's fair value. Investors should weigh the company's pipeline updates carefully amid these divergent valuation metrics.

Latest article

Newmont earnings today: Gold miner beats Q1 profit, adds $6 billion buyback but warns on Q2 costs

Newmont earnings today: Gold miner beats Q1 profit, adds $6 billion buyback but warns on Q2 costs

24 April 2026
Newmont reported adjusted first-quarter earnings of $2.90 per share on $7.31 billion in sales, beating estimates as realized gold prices surged to $4,900 an ounce. Attributable gold output fell to 1.30 million ounces from 1.54 million a year earlier. The miner declared a $0.26 dividend and authorized a new $6 billion share buyback. Newmont expects higher costs and lower output in the second quarter.
SAP Q1 Earnings Beat Forecasts as Cloud Revenue Climbs 27% in Constant Currencies, Outlook Holds

SAP Q1 Earnings Beat Forecasts as Cloud Revenue Climbs 27% in Constant Currencies, Outlook Holds

24 April 2026
SAP reported a 17% rise in first-quarter operating profit to 2.74 billion euros and a 19% jump in cloud revenue to 5.96 billion euros, beating forecasts. The company kept its 2026 targets and full-year outlook unchanged. SAP’s U.S. shares reversed losses after the results, climbing nearly 7% in after-hours trading. Management warned cloud revenue growth will slow in the second quarter.
MaxLinear Stock Surges as AI Data-Center Chip Demand Drives Big Q2 Outlook

MaxLinear Stock Surges as AI Data-Center Chip Demand Drives Big Q2 Outlook

24 April 2026
MaxLinear forecast second-quarter revenue of $160 million to $170 million, well above Wall Street’s estimate of $137.1 million. First-quarter revenue rose 43% to $137.2 million, driven by demand for optical products in AI data centers. Shares surged over 23% to $42.47 in after-hours trading. Infrastructure revenue jumped 136% from a year earlier, becoming the company’s largest segment.
Occidental Petroleum Stock in Focus as $100 Oil Pushes OXY to $59
Previous Story

Occidental Petroleum Stock in Focus as $100 Oil Pushes OXY to $59

Pfizer Stock Price Today: Shares Slip After GSK RSV Move Offsets Eliquis Data
Next Story

Pfizer Stock Price Today: Shares Slip After GSK RSV Move Offsets Eliquis Data

Go toTop